trending Market Intelligence /marketintelligence/en/news-insights/trending/kowjcxrvyyvwyyaitgtwna2 content esgSubNav
In This List

InVivo Therapeutics appoints acting CEO to permanent role

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


InVivo Therapeutics appoints acting CEO to permanent role

InVivo Therapeutics Holdings Corp. appointed Richard Toselli as the company's CEO and president.

Toselli, who is also the company's chief medical officer, has been acting as CEO since December 2017.

InVivo said Toselli will maintain the chief medical officer position and will join the board as a director.